Evidence map›Paper›PMID 37384251›Full record

ArticleFrontiers in cell and developmental biology2023

Potential alternative drug treatment for bone giant cell tumor.

Zhangxin Chen, Cong Zhang, Haisen Hong, Wenbin Xu, Mo Sha, Zhenqi Ding

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Surgical and radiological outcomes of giant cell tumor of the bone: prognostic value of Campanacci grading and selective use of denosumab.Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology · 2025
    Article
  2. Cellular crosstalk in the bone marrow niche.Journal of translational medicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Zhangxin ChenDepartment of Orthopedics, The 909th Hospital, School of Medicine, Xiamen University, Zhangzhou, China.
Cong ZhangDepartment of Orthopedics, The 909th Hospital, School of Medicine, Xiamen University, Zhangzhou, China.
Haisen HongDepartment of Orthopedics, The 909th Hospital, School of Medicine, Xiamen University, Zhangzhou, China.
Wenbin XuSchool of Medicine, Xiamen University, Xiamen, China.
Mo ShaDepartment of Orthopedics, The 909th Hospital, School of Medicine, Xiamen University, Zhangzhou, China.
Zhenqi DingDepartment of Orthopedics, The 909th Hospital, School of Medicine, Xiamen University, Zhangzhou, China.
Xiamen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bone giant cell tumordrug treatmentfracture healingpotential drugspotential genes

Identifiers

PMID37384251
PMCPMC10294225
OpenAlexW4380631598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.